Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report

Figure 1 Location map of the liver tumor.

Figure 2 Histology. A: Pathological staining of the resected liver cancer tissue at Zhongshan Hospital, Shanghai in October 2016 (G1S3); B: Liver puncture biopsy (G2S1) performed at Quanzhou First Hospital in July 2020.

Figure 3 Changes in the laboratory examination results during treatment. A: Changes in the hepatitis B virology indices HBsAg and HBsAb; B: Changes in alanine aminotransferase and aspartate aminotransferase levels, and platelet count. ETV: Entecavir; Peg-IFNα: Pegylated interferon alpha-2b; HBV: Hepatitis B virus; AST: Alanine aminotransferase; ALT: Aspartate aminotransferase; PLT: Platelet count.